These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 22528474)
1. Neuroimaging markers of human immunodeficiency virus infection in South Africa. Heaps JM; Joska J; Hoare J; Ortega M; Agrawal A; Seedat S; Ances BM; Stein DJ; Paul R J Neurovirol; 2012 Jun; 18(3):151-6. PubMed ID: 22528474 [TBL] [Abstract][Full Text] [Related]
2. HIV clades B and C are associated with reduced brain volumetrics. Ortega M; Heaps JM; Joska J; Vaida F; Seedat S; Stein DJ; Paul R; Ances BM J Neurovirol; 2013 Oct; 19(5):479-87. PubMed ID: 24078556 [TBL] [Abstract][Full Text] [Related]
3. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand. Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J; J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494 [TBL] [Abstract][Full Text] [Related]
4. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B; J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960 [TBL] [Abstract][Full Text] [Related]
6. Independent effects of HIV, aging, and HAART on brain volumetric measures. Ances BM; Ortega M; Vaida F; Heaps J; Paul R J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity. Paul RH; Phillips S; Hoare J; Laidlaw DH; Cabeen R; Olbricht GR; Su Y; Stein DJ; Engelbrecht S; Seedat S; Salminen LE; Baker LM; Heaps J; Joska J J Neurovirol; 2017 Apr; 23(2):319-328. PubMed ID: 27913960 [TBL] [Abstract][Full Text] [Related]
8. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183 [TBL] [Abstract][Full Text] [Related]
9. Clinical factors related to brain structure in HIV: the CHARTER study. Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I; J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705 [TBL] [Abstract][Full Text] [Related]
10. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era. Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254 [TBL] [Abstract][Full Text] [Related]
15. Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease. Paul RH; Joska JA; Woods C; Seedat S; Engelbrecht S; Hoare J; Heaps J; Valcour V; Ances B; Baker LM; Salminen LE; Stein DJ J Neurovirol; 2014 Dec; 20(6):627-35. PubMed ID: 25366660 [TBL] [Abstract][Full Text] [Related]
16. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B; J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212 [TBL] [Abstract][Full Text] [Related]
17. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Stout JC; Ellis RJ; Jernigan TL; Archibald SL; Abramson I; Wolfson T; McCutchan JA; Wallace MR; Atkinson JH; Grant I Arch Neurol; 1998 Feb; 55(2):161-8. PubMed ID: 9482357 [TBL] [Abstract][Full Text] [Related]
18. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734 [TBL] [Abstract][Full Text] [Related]
19. Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. Guha A; Brier MR; Ortega M; Westerhaus E; Nelson B; Ances BM J Acquir Immune Defic Syndr; 2016 Dec; 73(4):374-383. PubMed ID: 27454251 [TBL] [Abstract][Full Text] [Related]
20. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]